News & Updates

The risk of myopericarditis after COVID-19 vaccination is not greater than that following other non–COVID-19 vaccinations, according to a systematic review and meta-analysis conducted by researchers in Singapore.

In patients with type 2 diabetes mellitus (T2DM), abdominal aortic calcification might be an important indicator of coronary artery disease (CAD) and cerebral infarction (CI), a new study has found.

In the treatment and prevention of recurrent yeast infection or vulvovaginal candidiasis, oteseconazole performs similarly to standard-of-care fluconazole but better as compared with placebo, as shown in the results of the phase III ultraviolet study.

Patients with acute Kawasaki disease (KD) may develop a rare complication called atlantoaxial rotatory fixation (AARF), which must be taken into account if cervical symptoms present in older patients with atypical KD, suggests a study.

Treatment with abrocitinib is both safe and effective in patients with moderate-to-severe atopic dermatitis (AD), regardless of prior dupilumab response status, a study has shown.

The sodium-glucose cotransporter 2 inhibitor empagliflozin showed potential as a treatment alternative for hyponatremia due to chronic syndrome of inadequate antidiuresis (SIAD), according to a trial presented at ENDO 2022.

For male patients with inflammatory bowel disease (IBD), treatment with biologic, thiopurine, or methotrexate does not appear to promote impairments in fertility or adverse pregnancy outcomes, according to a study.